(SPAQ) Horizon Kinetics SPAC Active - Ratings and Ratios

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US53656G5559

SPAC Securities, Stocks, Healthcare Equities

Description: SPAQ Horizon Kinetics SPAC Active

The fund is an actively-managed exchange-traded fund that pursues its investment objective primarily by investing, under normal circumstances, in special purpose acquisition companies ('SPACs') that, the fund's investment sub-adviser, believes will generate net realized capital gains in excess of the income derived from bank certificates of deposit with similar maturities. The fund is non-diversified.

SPAQ ETF Overview

Market Cap in USD 13m
Category Health
TER 0.85%
IPO / Inception 2007-06-29

SPAQ ETF Ratings

Growth Rating 79.1%
Fundamental -
Dividend Rating 56.6%
Return 12m vs S&P 500 -9.38%
Analyst Rating -

SPAQ Dividends

Dividend Yield 12m 2.90%
Yield on Cost 5y 3.30%
Annual Growth 5y 7.95%
Payout Consistency 100.0%
Payout Ratio %

SPAQ Growth Ratios

Growth Correlation 3m -77.2%
Growth Correlation 12m 96.3%
Growth Correlation 5y 98.6%
CAGR 5y 7.47%
CAGR/Max DD 5y 1.84
CAGR/Mean DD 5y 51.30
Sharpe Ratio 12m 0.33
Alpha 3.07
Beta 0.121
Volatility 2.88%
Current Volume 0k
Average Volume 20d 0.1k
Stop Loss 100.8 (-3%)
Signal 0.08

What is the price of SPAQ shares?

As of September 09, 2025, the stock is trading at USD 103.95 with a total of 29 shares traded.
Over the past week, the price has changed by -0.01%, over one month by -0.28%, over three months by -0.84% and over the past year by +8.48%.

Is Horizon Kinetics SPAC Active a good stock to buy?

Yes. Based on ValueRay's Analyses, Horizon Kinetics SPAC Active (NASDAQ:SPAQ) is currently (September 2025) a good stock to buy. It has a ValueRay Growth Rating of 79.10 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SPAQ is around 101.68 USD . This means that SPAQ is currently overvalued and has a potential downside of -2.18%.

Is SPAQ a buy, sell or hold?

Horizon Kinetics SPAC Active has no consensus analysts rating.

What are the forecasts/targets for the SPAQ price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 111.3 7.1%

Last update: 2025-08-30 04:57

SPAQ Fundamental Data Overview

Market Cap USD = 13.3m (13.3m USD * 1.0 USD.USD)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 0.1044
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 13.3m USD (13.3m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 13.3m)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 13.3m / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(13.3m)/V(0.0) * Re(6.46%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 6.46% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for SPAQ ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle